Navigation Links
China Yingxia International, Inc. Appoints New Vice President of Finance
Date:9/10/2008

HARBIN, China, Sept. 10 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the nutraceutical industry engaged in the development, manufacture and distribution of nutritional food products, dietary supplements, and personal care products in the People's Republic of China ("PRC"), today announced the appointment of Mr. Fanke Kong as its new Vice President of Finance. He will be in charge of financial and accounting operations and report to Mr. Ren Hu, China Yingxia's CFO.

Mr. Kong graduated from the Heilongjiang Industrial Transportation Management College with a major in accounting in 1990. However, he has over 28 years of professional experience in accounting and asset valuation. He has previously worked as an accountant, chief accountant, director of accounting, and CFO for various large manufacturing and real estate companies and group companies, as well as an accounting firm.

Mr. Kong, who is a Senior Accountant, is also a China CPA (Certified Public Accountant) and CPV (Certified Public Valuer). He has published several articles on accounting practices and management in professional journals and authored and edited a college textbook "Management Accounting" published by Heilongjiang People's Publishing House in January 1998.

"We are very happy to welcome Mr. Kong as Vice President of Finance," said Ms. Yingxia Jiao, CEO of China Yingxia. "His extensive background in accounting in large organizations will be a valuable asset to China Yingxia as we seek to strengthen our finance and accounting functions. We look forward to working with him."

About China Yingxia International, Inc

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ('Yingxia'), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang, Peoples Republic of China. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched products, organic rice products, raw cacti, cactus and other herbal-based supplements, cosmetics, personal care products, and Nestle products.

Safe Harbor Statement

The statements contained herein that are not historical facts are 'forward-looking statements' within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as 'believes,' 'expects,' 'may,' 'will,' 'should,' or 'anticipates,' 'expect' or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets or forecasting financial results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

For more information, please contact:

Company Contact:

Mr. Ren Hu

Chief Financial Officer

China Yingxia International, Inc.

Tel: +1-201-887-0415

Email: arenhu@gmail.com

Investor Relations Contact:

Mr. Crocker Coulson

President

CCG Investor Relations

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com

Web site: http://www.ccgir.com


'/>"/>
SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Provides Update on Construction of New Manufacturing Facility
2. China Biologic Products to Present at the SIG Beijing Management Summit
3. China Biologics Production Facility Renews GMP Certification
4. China Bio Energy Holdings Group Announces Participation in the Susquehanna Second Annual Beijing Management Summit
5. Plexus Announces Expansion in Hangzhou, China
6. China Sky One Medical, Inc. Approved to List on the NASDAQ Global Market
7. China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) Beijing Management Summit
8. ORBIS and Alcon Train Chinas Next Generation of Sight-Savers
9. China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base
10. MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
11. China Kangtai Cactus Biotech Announces Record Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Surgical Wound Market with the addition of its newest module, US Hemostats & ... market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
Breaking Biology News(10 mins):